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Diffuse pulmonary amyloidosis due to
Familial Mediterranean Fever, a rare
presentation
To the Editor,
Familial Mediterranean Fever (FMF) is a hereditary
disease characterized by sporadic, paroxysmal attacks of
fever and serosal inflammation described primarily in
several ethnic groups originating from Mediterranean
region. The most serious complication of FMF is chronic
renal failure (CRF) developing due to secondary amyloi-
dosis (1). Clinically evident lung involvement due to
FMF associated amyloidosis is extremely rare and occurs
in severe cases (2). On the other hand very fine amyloid
deposits can be recognized in the peripheral alveolar
septa in autopsies of FMF patients (1). Herein we present
a case of diffuse pulmonary amyloidosis due to FMF
in an asymptomatic patient referred to our clinic with
a preliminary diagnosis of miliary tuberculosis.
The patient was a 31-year-old man who had a miliary
pattern observed on a routine chest X-ray. He had
a diagnosis of FMF since he was 10-years-old, had
undergone a renal biopsy revealing amyloidosis when he
was 19 and had started hemodialysis when he was 25.
Unfortunately he stopped using colchicine at that time.
Past medical history was unremarkable for tuberculosis
or prior respiratory disease. Physical examination was
normal. Laboratory analysis revealed a high erythrocyte
sedimentation rate (65 mm/h, range: 020 mm/h), anemia
(Hb: 9.3 g/dl, range: 1214 g/dl), impaired renal function
(BUN: 33 mg/dl, range: 020 mg/dl; creatinine: 5.1 mg/dl,
range: 0.61.4 mg/dl), and hypoalbuminemia (3.1 g/dl,
range: 3.55.5 g/dl). p-ANCA, c-ANCA and Anti-
GBM antibody were all negative. Three sputum smears
and cultures were negative for tuberculosis. Respiratory
function tests revealed a restrictive flow pattern and a
decreased diffusion capacity. Oxygenation was normal.
High resolution computed tomography of the chest
demonstrated diffuse reticulo-nodular pattern (Fig. 1).
We retrospectively evaluated the prior routine chest
x-rays and realized that the same radiological findings
were also evident in the chest x-rays obtained within
the previous year. We performed transbronchial lung
biopsy from the right lower lobe and showed amyloid
deposition within the alveolar septal interstitium and the
walls of small blood vessels with green birefringence
under polarized light after staining with congo-
red. Amyloid deposition in the walls of vessels is seen
in Fig. 2.
Pulmonary complications of chronic renal failure
(CRF) include uremic pulmonary edema, pleural effu-
sion, interstitial fibrosis, and increased risk for certain
infections such as tuberculosis (3). Pulmonary amyloi-
dosis is a rare presentation in a patient with CRF due to
FMF. In the literature Erdem et al. (4) reported a diffuse
pulmonary amyloidosis case mimicking interstitial lung
disease. In that case there was an advanced picture of
interstitial pulmonary involvement with fibrotic changes
in addition to background emphysema. In the presented
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Fig. 1. High resolution computed tomography of the chest
demonstrated diffuse reticulo-nodular pattern.
Fig. 2. Amyloid deposition in the walls of vessels (400
Congo red).
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1
Citation: Libyan J Med 2012, 7: 18482 - http://dx.doi.org/10.3402/ljm.v7i0.18482patient there were prominent diffuse reticulo-nodular
pattern due to amyloidosis in a CRF patient due to
FMF. Regular colchicine treatment is of great importance
in reducing the development or progression of secondary
amyloidosis (5). The discontinuation of colchicine ther-
apy for a duration of 6 years might have caused diffuse
pulmonary amyloidosis.
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